Cargando…
Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries
We examine the evidence from the long-run abnormal returns using data for 76 health care and biopharmaceutical initial public offerings (IPOs) listed in a 29-year period between 1986 and 2014 in the Association of Southeast Asian Nations (ASEAN) countries such as Indonesia, Malaysia, Singapore, Thai...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798722/ https://www.ncbi.nlm.nih.gov/pubmed/28853306 http://dx.doi.org/10.1177/0046958017727105 |